| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 32 |
| 1 | METOPROLOL TARTRATE | 26 |
| 2 | PREDNISONE | 26 |
| 3 | ASPIRIN | 25 |
| 4 | ASPIRIN 325 MG | 24 |
| 5 | ASPIRIN 81 MG | 24 |
| 6 | ERGOCALCIFEROL | 24 |
| 7 | METOPROLOL | 24 |
| 8 | IBUPROFEN | 22 |
| 9 | BEVACIZUMAB | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORFIMER SODIUM | 2 | 0.0059 |
| 1 | AURANOFIN | 1 | 0.0049 |
| 2 | CEFUROXIME SODIUM | 4 | 0.0033 |
| 3 | BECLOMETHASONE DIPROPIONATE | 15 | 0.0026 |
| 4 | IBANDRONATE SODIUM | 8 | 0.0025 |
| 5 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 6 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 7 | LURBINECTEDIN | 2 | 0.0017 |
| 8 | ERYTHROMYCIN ETHYLSUCCINATE | 1 | 0.0016 |
| 9 | ALDESLEUKIN | 2 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 67 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 52 |
| 2 | Loop Diuretic [EPC] | 48 |
| 3 | Kinase Inhibitor [EPC] | 27 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 5 | Benzodiazepine [EPC] | 25 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 25 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 25 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 25 |
| 9 | Proton Pump Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Surfactant [EPC] | 1 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 4 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 5 | Actinomycin [EPC] | 1 | 0.0005 |
| 6 | Estrogen Receptor Antagonist [EPC] | 15 | 0.0004 |
| 7 | Macrolide Antimicrobial [EPC] | 18 | 0.0003 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |